Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-04-18Clinical Trial Update: Use of Tocilizumab Drug Levels to Optimize Treatment in RA [Phase 4]
A Phase 4 clinical trial exploring the use of tocilizumab drug levels to optimize treatment in rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2024-04-18Clinical Trial Update: Adalimumab Drug Optimisation in Rheumatoid Arthritis Using Therapeutic Drug Monitoring [Phase 4]
Phase 4 clinical trial update evaluating adalimumab optimization in rheumatoid arthritis using therapeutic drug monitoring (TDM).
-
CLINICAL_TRIALS trial_result · 2024-04-16Clinical Trial Update: Ultrasound Efficacy in Moderate Rheumatoid Arthritis [NA]
A completed clinical trial investigating ultrasound efficacy in moderate rheumatoid arthritis; results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-04-12Clinical Trial Update: Comparative Effectiveness Of Tumor Necrosis Factor Inhibitors And Tofacitinib Use In Earlier Lines Of Therapy And Use As Monotherapy.
A completed clinical trial comparing TNF inhibitors and tofacitinib in earlier lines of therapy and as monotherapy for rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2024-04-10Clinical Trial Update: Cilostazol and Methotrexate in Rheumatoid Arthritis [Phase 3]
Phase 3 clinical trial evaluating cilostazol in combination with methotrexate for rheumatoid arthritis is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-03-25Clinical Trial Update: Efficacy Study of Iguratimod Combined With Tofacitab in Patients With RF Positive/Negative Rheumatoid Arthritis [Phase 4]
Phase 4 clinical trial evaluating the efficacy of iguratimod combined with tofacitab in rheumatoid arthritis (RF positive/negative).
-
CLINICAL_TRIALS trial_result · 2024-03-21Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effects of Multiple Rising Subcutaneous Doses of BI 655064 in Healthy Volunteers and in Rheumatoid Arthritis Patients With Prior Inadequate Response to Methotrexate Therapy [Phase 1]
Phase 1 trial assessing safety, tolerability, pharmacokinetics, pharmacodynamics, and clinical effects of multiple rising subcutaneous doses…
-
CLINICAL_TRIALS trial_result · 2024-03-12Clinical Trial Update: A Study to Assess the Efficacy and Safety of Burfiralimab (hzVSF-v13) and DMRD (Disease-modifying Antirheumatic Drug) [Phase 2]
Phase 2 study evaluating the efficacy and safety of Burfiralimab plus a DMARD in moderate to severe rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2024-03-08Clinical Trial Update: Weight Loss and Exercise To Improve Rheumatoid Arthritis Cardiovascular Risk [NA]
A clinical trial evaluating weight loss and exercise to reduce cardiovascular risk in people with rheumatoid arthritis has completed and res…
-
CLINICAL_TRIALS trial_result · 2024-03-01Clinical Trial Update: A Phase 2 Study of Hemay007 in Patients With Rheumatoid Arthritis [Phase 2]
Phase 2 clinical trial update for Hemay007 in patients with rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: Stopping TNF Alpha Inhibitors in Rheumatoid Arthritis [Phase 4]
A Phase 4 clinical trial update exploring stopping TNF alpha inhibitors in rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2024-02-13Clinical Trial Update: Montelukast Use in Rheumatoid Arthritis [Phase 2]
Phase 2 clinical trial examining montelukast for rheumatoid arthritis has been completed.
-
CLINICAL_TRIALS trial_result · 2024-02-07Clinical Trial Update: Long-term Safety and Efficacy of GSK3196165 (Otilimab) in the Treatment of Rheumatoid Arthritis (RA) [Phase 3]
Phase 3 trial update for otilimab (GSK3196165) in rheumatoid arthritis shows termination with posted results.
-
CLINICAL_TRIALS trial_result · 2024-02-06Clinical Trial Update: Trivalent Chromium Treatment for Rheumatoid Arthritis [Phase 2, Phase 3]
A completed Phase 2/Phase 3 clinical trial evaluating trivalent chromium for rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2024-02-05Clinical Trial Update: An Observational Study to Evaluate Safety and Efficacy of Remsima™ in Patients With RA
Observational study evaluating safety and efficacy of Remsima in rheumatoid arthritis; the study was terminated but results were posted on F…
-
CLINICAL_TRIALS trial_result · 2024-01-30Clinical Trial Update: The Effects of Acthar on Synovial Inflammation in Rheumatoid Arthritis [Phase 3]
A Phase 3 clinical trial investigating the effects of Acthar on synovial inflammation in rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2024-01-16Clinical Trial Update: Study to Assess Safety and Effectiveness of Branebrutinib Treatment in Participants With Active Systemic Lupus Erythematosus or Primary Sjögren's Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Study Participants With Active Rheumatoid Arthritis [Phase 2]
Phase 2 trial assessing Branebrutinib in active autoimmune diseases (systemic lupus erythematosus, primary Sjögren's syndrome) and rheumatoi…
-
CLINICAL_TRIALS trial_result · 2023-12-13Clinical Trial Update: Study Comparing Etanercept Plus Methotrexate to Either Etanercept or Methotrexate Alone in Rheumatoid Arthritis. [Phase 3]
Phase 3 trial comparing combination therapy (etanercept plus methotrexate) to monotherapy (etanercept or methotrexate) in active rheumatoid …
-
CLINICAL_TRIALS trial_result · 2023-12-11Clinical Trial Update: An Extension Study of WA19926 of the Long-Term Safety of Tocilizumab (RoActemra/Actemra) in Patients With Early Moderate to Severe Rheumatoid Arthritis [Phase 3]
An extension study reports the long-term safety data for tocilizumab in patients with early moderate to severe rheumatoid arthritis. Complet…
-
CLINICAL_TRIALS trial_result · 2023-11-30Clinical Trial Update: Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic (cs)/Biologic (b) Disease Modifying Anti-rheumatic Drugs (DMARDs) [Phase 3]
Phase 3 trial evaluating GSK3196165 vs placebo and tofacitinib in adults with moderately to severely active rheumatoid arthritis who failed …
-
CLINICAL_TRIALS trial_result · 2023-11-28Clinical Trial Update: An Efficacy and Safety Study of Subcutaneous Tocilizumab in Combination With Methotrexate (MTX) and as Monotherapy Versus MTX in Participants With Moderate to Severe Rheumatoid Arthritis With Inadequate Response to Current Disease-Modifying Antirheumatic Drug (DMARD) Therapy [Phase 3]
Phase 3 study evaluating subcutaneous tocilizumab with methotrexate or as monotherapy versus MTX in moderate-to-severe rheumatoid arthritis …
-
CLINICAL_TRIALS trial_result · 2023-11-27Clinical Trial Update: Alendronate Treatment of Osteoporosis in Rheumatoid Arthritis [Phase 2]
Phase 2 clinical trial investigating alendronate for osteoporosis in patients with rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2023-11-22Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of SHR0302 in Patients With Rheumatoid Arthritis [Phase 3]
Phase 3 trial update for SHR0302 assessing efficacy and safety in rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2023-11-22Clinical Trial Update: A Study Of PF-04171327 In The Treatment Of The Signs And Symptoms Of Rheumatoid Arthritis [Phase 2]
Phase 2 trial of PF-04171327 for rheumatoid arthritis completed; results posted.
-
CLINICAL_TRIALS trial_result · 2023-11-21Clinical Trial Update: Strategy to Prevent the Onset of Clinically-Apparent Rheumatoid Arthritis [Phase 2]
Phase 2 trial update evaluating strategies to prevent clinically apparent rheumatoid arthritis. The study was terminated and results have be…